{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T10:49:41Z","timestamp":1792147781873,"version":"4.4.0"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T00:00:00Z","timestamp":1715990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T00:00:00Z","timestamp":1715990400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100019899","name":"Alliance Nationale pour les Sciences de la Vie et de la Sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019899","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-024-03877-2","type":"journal-article","created":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T13:01:46Z","timestamp":1716037306000},"page":"1058-1065","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Clinical and therapeutic implications of cavernous sinus invasion in pituitary adenomas"],"prefix":"10.1007","volume":"85","author":[{"given":"Etienne","family":"Lefevre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanny","family":"Chasseloup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirella","family":"Hage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Chanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Buchfelder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Kamenick\u00fd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,18]]},"reference":[{"issue":"4","key":"3877_CR1","doi-asserted-by":"publisher","first-page":"803","DOI":"10.3171\/2014.12.JNS141083","volume":"122","author":"ASG Micko","year":"2015","unstructured":"A.S.G. Micko, A. W\u00f6hrer, S. Wolfsberger, E. Knosp, Invasion of the cavernous sinus space in pituitary adenomas: endoscopic verification and its correlation with an MRI-based classification. J. Neurosurg. 122(4), 803\u2013811 (2015). https:\/\/doi.org\/10.3171\/2014.12.JNS141083","journal-title":"J. Neurosurg."},{"issue":"1","key":"3877_CR2","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3171\/2014.3.JNS131679","volume":"121","author":"K Juraschka","year":"2014","unstructured":"K. Juraschka, O.H. Khan, B.L. Godoy et al., Endoscopic endonasal transsphenoidal approach to large and giant pituitary adenomas: institutional experience and predictors of extent of resection. J. Neurosurg. 121(1), 75\u201383 (2014). https:\/\/doi.org\/10.3171\/2014.3.JNS131679","journal-title":"J. Neurosurg."},{"issue":"2","key":"3877_CR3","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1530\/EJE-10-0255","volume":"163","author":"S Brochier","year":"2010","unstructured":"S. Brochier, F. Galland, M. Kujas et al., Factors predicting relapse of nonfunctioning pituitary macroadenomas after neurosurgery: a study of 142 patients. Eur. J. Endocrinol. 163(2), 193\u2013200 (2010). https:\/\/doi.org\/10.1530\/EJE-10-0255","journal-title":"Eur. J. Endocrinol."},{"issue":"9","key":"3877_CR4","doi-asserted-by":"publisher","first-page":"3368","DOI":"10.1210\/jc.2017-00773","volume":"102","author":"G Raverot","year":"2017","unstructured":"G. Raverot, E. Dantony, J. Beauvy et al., Risk of recurrence in pituitary neuroendocrine tumors: a prospective study using a five-tiered classification. J. Clin. Endocrinol. Metab. 102(9), 3368\u20133374 (2017). https:\/\/doi.org\/10.1210\/jc.2017-00773","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"3877_CR5","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.nec.2019.05.005","volume":"30","author":"M Rutkowski","year":"2019","unstructured":"M. Rutkowski, G. Zada, Management of pituitary adenomas invading the cavernous sinus. Neurosurg. Clin. 30(4), 445\u2013455 (2019). https:\/\/doi.org\/10.1016\/j.nec.2019.05.005","journal-title":"Neurosurg. Clin."},{"key":"3877_CR6","doi-asserted-by":"crossref","unstructured":"M. Araujo-Castro, A. Acitores Cancela, C. Vior, E. Pascual-Corrales, V. Rodr\u00edguez Berrocal, Radiological Knosp, revised-Knosp, and Hardy\u2013Wilson classifications for the prediction of surgical outcomes in the endoscopic endonasal surgery of pituitary adenomas: study of 228 cases. Front. Oncol. 11 (2022). https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2021.807040","DOI":"10.3389\/fonc.2021.807040"},{"issue":"4","key":"3877_CR7","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1227\/00006123-199310000-00008","volume":"33","author":"E Knosp","year":"1993","unstructured":"E. Knosp, E. Steiner, K. Kitz, C. Matula, Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings. Neurosurgery 33(4), 610\u2013617 (1993). https:\/\/doi.org\/10.1227\/00006123-199310000-00008.","journal-title":"Neurosurgery"},{"issue":"3","key":"3877_CR8","doi-asserted-by":"publisher","first-page":"505","DOI":"10.3171\/2014.3.JNS132214","volume":"121","author":"H Nishioka","year":"2014","unstructured":"H. Nishioka, N. Fukuhara, K. Horiguchi, S. Yamada, Aggressive transsphenoidal resection of tumors invading the cavernous sinus in patients with acromegaly: predictive factors, strategies, and outcomes. J. Neurosurg. 121(3), 505\u2013510 (2014). https:\/\/doi.org\/10.3171\/2014.3.JNS132214","journal-title":"J. Neurosurg."},{"issue":"6","key":"3877_CR9","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.3171\/2019.3.JNS19367","volume":"132","author":"A Micko","year":"2019","unstructured":"A. Micko, J. Oberndorfer, W.J. Weninger et al., Challenging Knosp high-grade pituitary adenomas. J. Neurosurg. 132(6), 1739\u20131746 (2019). https:\/\/doi.org\/10.3171\/2019.3.JNS19367","journal-title":"J. Neurosurg."},{"issue":"1","key":"3877_CR10","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3390\/life13010049","volume":"13","author":"F Eisenhut","year":"2022","unstructured":"F. Eisenhut, M.A. Schmidt, M. Buchfelder, A. Doerfler, S.M. Schlaffer, Improved detection of cavernous sinus invasion of pituitary macroadenomas with ultra-high-field 7 T MRI. Life13(1), 49 (2022). https:\/\/doi.org\/10.3390\/life13010049","journal-title":"Life"},{"issue":"1","key":"3877_CR11","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3171\/2018.3.JNS18596","volume":"131","author":"HQ Truong","year":"2018","unstructured":"H.Q. Truong, S. Lieber, E. Najera, J.T. Alves-Belo, P.A. Gardner, J.C. Fernandez-Miranda, The medial wall of the cavernous sinus. Part 1: surgical anatomy, ligaments, and surgical technique for its mobilization and\/or resection. J. Neurosurg. 131(1), 122\u2013130 (2018). https:\/\/doi.org\/10.3171\/2018.3.JNS18596","journal-title":"J. Neurosurg."},{"issue":"1","key":"3877_CR12","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3171\/2018.5.JNS18595","volume":"131","author":"S Cohen-Cohen","year":"2018","unstructured":"S. Cohen-Cohen, P.A. Gardner, J.T. Alves-Belo et al., The medial wall of the cavernous sinus. Part 2: selective medial wall resection in 50 pituitary adenoma patients. J. Neurosurg. 131(1), 131\u2013140 (2018). https:\/\/doi.org\/10.3171\/2018.5.JNS18595","journal-title":"J. Neurosurg."},{"issue":"1","key":"3877_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-12980-1","volume":"12","author":"A Mohyeldin","year":"2022","unstructured":"A. Mohyeldin, L.J. Katznelson, A.R. Hoffman et al., Prospective intraoperative and histologic evaluation of cavernous sinus medial wall invasion by pituitary adenomas and its implications for acromegaly remission outcomes. Sci. Rep. 12(1), 9919 (2022). https:\/\/doi.org\/10.1038\/s41598-022-12980-1","journal-title":"Sci. Rep."},{"key":"3877_CR14","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.wneu.2016.08.088","volume":"96","author":"S Dhandapani","year":"2016","unstructured":"S. Dhandapani, H. Singh, H.M. Negm, S. Cohen, V.K. Anand, T.H. Schwartz, Cavernous sinus invasion in pituitary adenomas: systematic review and pooled data meta-analysis of radiologic criteria and comparison of endoscopic and microscopic surgery. World Neurosurg. 96, 36\u201346 (2016). https:\/\/doi.org\/10.1016\/j.wneu.2016.08.088","journal-title":"World Neurosurg."},{"issue":"5","key":"3877_CR15","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.3171\/2014.1.JNS131228","volume":"120","author":"GF Woodworth","year":"2014","unstructured":"G.F. Woodworth, K.S. Patel, B. Shin et al., Surgical outcomes using a medial-to-lateral endonasal endoscopic approach to pituitary adenomas invading the cavernous sinus. J. Neurosurg. 120(5), 1086\u20131094 (2014). https:\/\/doi.org\/10.3171\/2014.1.JNS131228","journal-title":"J. Neurosurg."},{"issue":"4","key":"3877_CR16","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s11102-013-0502-4","volume":"17","author":"A Paluzzi","year":"2014","unstructured":"A. Paluzzi, J.C. Fernandez-Miranda, S. Tonya Stefko, S. Challinor, C.H. Snyderman, P.A. Gardner, Endoscopic endonasal approach for pituitary adenomas: a series of 555 patients. Pituitary 17(4), 307\u2013319 (2014). https:\/\/doi.org\/10.1007\/s11102-013-0502-4","journal-title":"Pituitary"},{"issue":"3","key":"3877_CR17","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1007\/s11102-011-0350-z","volume":"15","author":"CP Hofstetter","year":"2012","unstructured":"C.P. Hofstetter, M.J. Nanaszko, L.L. Mubita, J. Tsiouris, V.K. Anand, T.H. Schwartz, Volumetric classification of pituitary macroadenomas predicts outcome and morbidity following endoscopic endonasal transsphenoidal surgery. Pituitary 15(3), 450\u2013463 (2012). https:\/\/doi.org\/10.1007\/s11102-011-0350-z","journal-title":"Pituitary"},{"issue":"4","key":"3877_CR18","doi-asserted-by":"publisher","first-page":"E11","DOI":"10.3171\/2011.1.FOCUS10308","volume":"30","author":"M Messerer","year":"2011","unstructured":"M. Messerer, J.C. De Battista, G. Raverot et al., Evidence of improved surgical outcome following endoscopy for nonfunctioning pituitary adenoma removal. Neurosurg. Focus 30(4), E11 (2011). https:\/\/doi.org\/10.3171\/2011.1.FOCUS10308","journal-title":"Neurosurg. Focus"},{"key":"3877_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3171\/2023.3.JNS221949","volume":"1","author":"K Asmaro","year":"2023","unstructured":"K. Asmaro, M. Zhang, A.J. Rodrigues et al., Cytodifferentiation of pituitary tumors influences pathogenesis and cavernous sinus invasion. J. Neurosurg. 1, 1\u20139 (2023). https:\/\/doi.org\/10.3171\/2023.3.JNS221949","journal-title":"J. Neurosurg."},{"issue":"17","key":"3877_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00029679-198911170-00001","volume":"11","author":"R Fahlbusch","year":"1989","unstructured":"R. Fahlbusch, M. Buchfelder, Current management of invasive pituitary adenomas. Contemp. Neurosurg. 11(17), 1 (1989)","journal-title":"Contemp. Neurosurg."},{"issue":"24","key":"3877_CR21","doi-asserted-by":"publisher","first-page":"e3904","DOI":"10.1097\/MD.0000000000003904","volume":"95","author":"HY Liu","year":"2016","unstructured":"H.Y. Liu, W.J. Gu, C.Z. Wang, X.J. Ji, Y.M. Mu, Matrix metalloproteinase-9 and -2 and tissue inhibitor of matrix metalloproteinase-2 in invasive pituitary adenomas. Medicine 95(24), e3904 (2016). https:\/\/doi.org\/10.1097\/MD.0000000000003904","journal-title":"Medicine"},{"issue":"1","key":"3877_CR22","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s11102-007-0066-2","volume":"11","author":"J Gong","year":"2008","unstructured":"J. Gong, Y. Zhao, R. Abdel-Fattah et al., Matrix metalloproteinase-9, a potential biological marker in invasive pituitary adenomas. Pituitary 11(1), 37\u201348 (2008). https:\/\/doi.org\/10.1007\/s11102-007-0066-2","journal-title":"Pituitary"},{"issue":"4","key":"3877_CR23","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1007\/BF01420300","volume":"138","author":"H Kawamoto","year":"1996","unstructured":"H. Kawamoto, T. Uozumi, K. Kawamoto, K. Arita, T. Yano, T. Hirohata, Type IV collagenase activity and cavernous sinus invasion in human pituitary adenomas. Acta Neurochir. 138(4), 390\u2013395 (1996). https:\/\/doi.org\/10.1007\/BF01420300","journal-title":"Acta Neurochir."},{"issue":"2","key":"3877_CR24","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1210\/endrev\/bnac024","volume":"44","author":"MD Ilie","year":"2023","unstructured":"M.D. Ilie, A. Vasiljevic, P. Bertolino, G. Raverot, Biological and therapeutic implications of the tumor microenvironment in pituitary adenomas. Endocr. Rev. 44(2), 297\u2013311 (2023). https:\/\/doi.org\/10.1210\/endrev\/bnac024","journal-title":"Endocr. Rev."},{"issue":"10","key":"3877_CR25","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.3390\/cancers11101605","volume":"11","author":"MD Ilie","year":"2019","unstructured":"M.D. Ilie, A. Vasiljevic, G. Raverot, P. Bertolino, The microenvironment of pituitary tumors\u2014biological and therapeutic implications. Cancers 11(10), 1605 (2019). https:\/\/doi.org\/10.3390\/cancers11101605","journal-title":"Cancers"},{"issue":"5","key":"3877_CR26","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s00401-003-0747-5","volume":"106","author":"UJ Knappe","year":"2003","unstructured":"U.J. Knappe, C. Hagel, B.W. Lisboa, W. Wilczak, D.K. L\u00fcdecke, W. Saeger, Expression of serine proteases and metalloproteinases in human pituitary adenomas and anterior pituitary lobe tissue. Acta Neuropathol. 106(5), 471\u2013478 (2003). https:\/\/doi.org\/10.1007\/s00401-003-0747-5","journal-title":"Acta Neuropathol."},{"issue":"2","key":"3877_CR27","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1677\/ERC-10-0018","volume":"17","author":"F Galland","year":"2010","unstructured":"F. Galland, L. Lacroix, P. Saulnier et al., Differential gene expression profiles of invasive and non-invasive non-functioning pituitary adenomas based on microarray analysis. Endocr. Relat. Cancer 17(2), 361\u2013371 (2010). https:\/\/doi.org\/10.1677\/ERC-10-0018","journal-title":"Endocr. Relat. Cancer"},{"issue":"5","key":"3877_CR28","doi-asserted-by":"publisher","first-page":"695","DOI":"10.3390\/jcm8050695","volume":"8","author":"M Sato","year":"2019","unstructured":"M. Sato, R. Tamura, H. Tamura et al., Analysis of tumor angiogenesis and immune microenvironment in non-functional pituitary endocrine tumors. J. Clin. Med. 8(5), 695 (2019). https:\/\/doi.org\/10.3390\/jcm8050695","journal-title":"J. Clin. Med."},{"issue":"8","key":"3877_CR29","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1093\/neuonc\/noaa084","volume":"22","author":"C Shi","year":"2020","unstructured":"C. Shi, Z. Ye, J. Han et al., BRD4 as a therapeutic target for nonfunctioning and growth hormone pituitary adenoma. Neuro Oncol. 22(8), 1114\u20131125 (2020). https:\/\/doi.org\/10.1093\/neuonc\/noaa084","journal-title":"Neuro Oncol."},{"issue":"5","key":"3877_CR30","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1210\/jc.2017-02287","volume":"103","author":"M Hage","year":"2018","unstructured":"M. Hage, S. Viengchareun, E. Brunet et al., Genomic alterations and complex subclonal architecture in sporadic GH-secreting pituitary adenomas. J. Clin. Endocrinol. Metab. 103(5), 1929\u20131939 (2018). https:\/\/doi.org\/10.1210\/jc.2017-02287","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"7467","key":"3877_CR31","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/nature12625","volume":"501","author":"RA Burrell","year":"2013","unstructured":"R.A. Burrell, N. McGranahan, J. Bartek, C. Swanton, The causes and consequences of genetic heterogeneity in cancer evolution. Nature 501(7467), 338\u2013345 (2013). https:\/\/doi.org\/10.1038\/nature12625","journal-title":"Nature"},{"issue":"11","key":"3877_CR32","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/s41574-021-00550-w","volume":"17","author":"G Raverot","year":"2021","unstructured":"G. Raverot, M.D. Ilie, H. Lasolle et al., Aggressive pituitary tumours and pituitary carcinomas. Nat. Rev. Endocrinol. 17(11), 671\u2013684 (2021). https:\/\/doi.org\/10.1038\/s41574-021-00550-w","journal-title":"Nat. Rev. Endocrinol."},{"key":"3877_CR33","doi-asserted-by":"publisher","unstructured":"P. Marques, S. Barry, E. Carlsen et al., The role of the tumour microenvironment in the angiogenesis of pituitary tumours. Endocrine 70(3) (2020). https:\/\/doi.org\/10.1007\/s12020-020-02478-z","DOI":"10.1007\/s12020-020-02478-z"},{"issue":"1","key":"3877_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-019-0830-3","volume":"7","author":"P Marques","year":"2019","unstructured":"P. Marques, S. Barry, E. Carlsen et al., Chemokines modulate the tumour microenvironment in pituitary neuroendocrine tumours. Acta Neuropathol. Commun. 7(1), 172 (2019). https:\/\/doi.org\/10.1186\/s40478-019-0830-3","journal-title":"Acta Neuropathol. Commun."},{"issue":"27","key":"3877_CR35","doi-asserted-by":"publisher","first-page":"5381","DOI":"10.1038\/s41388-019-0779-5","volume":"38","author":"S Barry","year":"2019","unstructured":"S. Barry, E. Carlsen, P. Marques et al., Tumor microenvironment defines the invasive phenotype of AIP-mutation-positive pituitary tumors. Oncogene 38(27), 5381\u20135395 (2019). https:\/\/doi.org\/10.1038\/s41388-019-0779-5","journal-title":"Oncogene"},{"issue":"8","key":"3877_CR36","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.3390\/jcm8081107","volume":"8","author":"MD Ilie","year":"2019","unstructured":"M.D. Ilie, H. Lasolle, G. Raverot, Emerging and novel treatments for pituitary tumors. J. Clin. Med. 8(8), 1107 (2019). https:\/\/doi.org\/10.3390\/jcm8081107","journal-title":"J. Clin. Med"},{"issue":"3","key":"3877_CR37","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1055\/a-1260-3975","volume":"129","author":"K Osterhage","year":"2021","unstructured":"K. Osterhage, R. Rotermund, M. Droste et al., Bevacizumab in aggressive pituitary adenomas \u2013 experience with 3 patients. Exp. Clin. Endocrinol. Diabetes 129(3), 178\u2013185 (2021). https:\/\/doi.org\/10.1055\/a-1260-3975","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"issue":"2","key":"3877_CR38","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1007\/s12022-019-9568-5","volume":"30","author":"OM Alshaikh","year":"2019","unstructured":"O.M. Alshaikh, S.L. Asa, O. Mete, S. Ezzat, An institutional experience of tumor progression to pituitary carcinoma in a 15-year cohort of 1055 consecutive pituitary neuroendocrine tumors. Endocr. Pathol. 30(2), 118\u2013127 (2019). https:\/\/doi.org\/10.1007\/s12022-019-9568-5","journal-title":"Endocr. Pathol."},{"issue":"7","key":"3877_CR39","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1530\/ERC-22-0037","volume":"29","author":"MD Ilie","year":"2022","unstructured":"M.D. Ilie, A. Vasiljevic, E. Jouanneau, G. Raverot, Immunotherapy in aggressive pituitary tumors and carcinomas: a systematic review. Endocr. Relat. Cancer 29(7), 415\u2013426 (2022). https:\/\/doi.org\/10.1530\/ERC-22-0037","journal-title":"Endocr. Relat. Cancer"},{"issue":"5","key":"3877_CR40","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1530\/EJE-22-0647","volume":"187","author":"MD Ilie","year":"2022","unstructured":"M.D. Ilie, C. Villa, T. Cuny et al., Real-life efficacy and predictors of response to immunotherapy in pituitary tumors: a cohort study. Eur. J. Endocrinol. 187(5), 685\u2013696 (2022). https:\/\/doi.org\/10.1530\/EJE-22-0647","journal-title":"Eur. J. Endocrinol."},{"issue":"4","key":"3877_CR41","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1097\/00006123-200110000-00014","volume":"49","author":"S Yokoyama","year":"2001","unstructured":"S. Yokoyama, H. Hirano, K. Moroki, M. Goto, S. Imamura, J.I. Kuratsu, Are nonfunctioning pituitary adenomas extending into the cavernous sinus aggressive and\/or invasive? Neurosurgery 49(4), 857\u2013862 (2001). https:\/\/doi.org\/10.1097\/00006123-200110000-00014.","journal-title":"Neurosurgery"},{"issue":"1","key":"3877_CR42","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1227\/01.NEU.0000126953.59406.77","volume":"55","author":"A Yasuda","year":"2004","unstructured":"A. Yasuda, A. Campero, C. Martins, A.L.J. Rhoton, G.C. Ribas, The medial wall of the cavernous sinus: microsurgical anatomy. Neurosurgery 55(1), 179 (2004). https:\/\/doi.org\/10.1227\/01.NEU.0000126953.59406.77","journal-title":"Neurosurgery"},{"issue":"2","key":"3877_CR43","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s10143-011-0360-3","volume":"35","author":"MB Gon\u00e7alves","year":"2012","unstructured":"M.B. Gon\u00e7alves, J.G. de Oliveira, H.A. Williams, R.M.P. Alvarenga, J.A. Landeiro, Cavernous sinus medial wall: dural or fibrous layer? Systematic review of the literature. Neurosurg. Rev. 35(2), 147\u2013154 (2012). https:\/\/doi.org\/10.1007\/s10143-011-0360-3","journal-title":"Neurosurg. Rev."},{"key":"3877_CR44","doi-asserted-by":"publisher","unstructured":"J.P. Cottier, C. Destrieux, L. Brunereau, et al., Cavernous sinus invasion by pituitary adenoma: MR imaging. Radiology (2000). https:\/\/doi.org\/10.1148\/radiology.215.2.r00ap18463","DOI":"10.1148\/radiology.215.2.r00ap18463"},{"key":"3877_CR45","doi-asserted-by":"publisher","first-page":"ons106","DOI":"10.1227\/NEU.0b013e3182889f2b","volume":"73","author":"Y Diao","year":"2013","unstructured":"Y. Diao, L. Liang, C. Yu, M. Zhang, Is there an identifiable intact medial wall of the cavernous sinus? Macro- and microscopic anatomical study using sheet plastination. Neurosurgery 73, ons106\u2013ons109 (2013). https:\/\/doi.org\/10.1227\/NEU.0b013e3182889f2b.","journal-title":"Neurosurgery"},{"issue":"5","key":"3877_CR46","doi-asserted-by":"publisher","first-page":"3381","DOI":"10.1007\/s10143-022-01846-9","volume":"45","author":"K Shi","year":"2022","unstructured":"K. Shi, Z. Li, X. Wu et al., The medial wall and medial compartment of the cavernous sinus: an anatomic study using plastinated histological sections. Neurosurg. Rev. 45(5), 3381\u20133391 (2022). https:\/\/doi.org\/10.1007\/s10143-022-01846-9","journal-title":"Neurosurg. Rev."},{"issue":"6","key":"3877_CR47","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1002\/ca.20160","volume":"18","author":"S Yilmazlar","year":"2005","unstructured":"S. Yilmazlar, H. Kocaeli, F. Aydiner, E. Korfali, Medial portion of the cavernous sinus: quantitative analysis of the medial wall. Clin. Anat. 18(6), 416\u2013422 (2005). https:\/\/doi.org\/10.1002\/ca.20160","journal-title":"Clin. Anat."},{"key":"3877_CR48","doi-asserted-by":"publisher","unstructured":"V.V. Dolenc (ed.), Anatomy of the cavernous sinus. in Anatomy and Surgery of the Cavernous Sinus. (Springer; 1989), pp. 3\u2013137. https:\/\/doi.org\/10.1007\/978-3-7091-6942-1_2","DOI":"10.1007\/978-3-7091-6942-1_2"},{"issue":"12","key":"3877_CR49","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1016\/j.jocn.2006.07.016","volume":"14","author":"SH Kim","year":"2007","unstructured":"S.H. Kim, K.C. Lee, S.H. Kim, Cranial nerve palsies accompanying pituitary tumour. J. Clin. Neurosci. 14(12), 1158\u20131162 (2007). https:\/\/doi.org\/10.1016\/j.jocn.2006.07.016","journal-title":"J. Clin. Neurosci."},{"issue":"4","key":"3877_CR50","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s11102-012-0444-2","volume":"16","author":"N Cinar","year":"2013","unstructured":"N. Cinar, Y. Tekinel, S. Dagdelen, H. Oruckaptan, F. Soylemezoglu, T. Erbas, Cavernous sinus invasion might be a risk factor for apoplexy. Pituitary 16(4), 483\u2013489 (2013). https:\/\/doi.org\/10.1007\/s11102-012-0444-2","journal-title":"Pituitary"},{"key":"3877_CR51","doi-asserted-by":"publisher","first-page":"e723","DOI":"10.1016\/j.wneu.2019.02.138","volume":"126","author":"A Hosmann","year":"2019","unstructured":"A. Hosmann, A. Micko, J.M. Frischer et al., Multiple pituitary apoplexy-cavernous sinus invasion as major risk factor for recurrent hemorrhage. World Neurosurg. 126, e723\u2013e730 (2019). https:\/\/doi.org\/10.1016\/j.wneu.2019.02.138","journal-title":"World Neurosurg."},{"issue":"1","key":"3877_CR52","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/jon.13051","volume":"33","author":"A Dincer","year":"2023","unstructured":"A. Dincer, V. Sharma, N. Madan, C. Heilman, Cavernous segment internal carotid artery stenosis specific to meningiomas compared to pituitary adenomas. J. Neuroimaging 33(1), 73\u201378 (2023). https:\/\/doi.org\/10.1111\/jon.13051","journal-title":"J. Neuroimaging"},{"issue":"10","key":"3877_CR53","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1056\/NEJMra1810772","volume":"382","author":"S Melmed","year":"2020","unstructured":"S. Melmed, Pituitary-tumor endocrinopathies. N. Engl. J. Med. 382(10), 937\u2013950 (2020). https:\/\/doi.org\/10.1056\/NEJMra1810772","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"3877_CR54","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1007\/s11102-016-0765-7","volume":"20","author":"M Buchfelder","year":"2017","unstructured":"M. Buchfelder, S.M. Schlaffer, The surgical treatment of acromegaly. Pituitary 20(1), 76\u201383 (2017). https:\/\/doi.org\/10.1007\/s11102-016-0765-7","journal-title":"Pituitary"},{"issue":"5","key":"3877_CR55","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1530\/eje.1.01896","volume":"152","author":"J Wass","year":"2005","unstructured":"J. Wass, Debulking of pituitary adenomas improves hormonal control of acromegaly by somatostatin analogues. Eur. J. Endocrinol. 152(5), 693\u2013694 (2005). https:\/\/doi.org\/10.1530\/eje.1.01896","journal-title":"Eur. J. Endocrinol."},{"issue":"1","key":"3877_CR56","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1210\/jc.2005-1208","volume":"91","author":"A Colao","year":"2006","unstructured":"A. Colao, R. Attanasio, R. Pivonello et al., Partial surgical removal of growth hormone-secreting pituitary tumors enhances the response to somatostatin analogs in acromegaly. J. Clin. Endocrinol. Metab. 91(1), 85\u201392 (2006). https:\/\/doi.org\/10.1210\/jc.2005-1208","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"3877_CR57","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1111\/j.1365-2265.2007.02885.x","volume":"67","author":"RS Jallad","year":"2007","unstructured":"R.S. Jallad, N.R. Musolino, S. Kodaira, V.A. Cescato, M.D. Bronstein, Does partial surgical tumour removal influence the response to octreotide-LAR in acromegalic patients previously resistant to the somatostatin analogue? Clin. Endocrinol. 67(2), 310\u2013315 (2007). https:\/\/doi.org\/10.1111\/j.1365-2265.2007.02885.x","journal-title":"Clin. Endocrinol."},{"issue":"6","key":"3877_CR58","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1111\/j.1365-2265.2007.03139.x","volume":"68","author":"N Karavitaki","year":"2008","unstructured":"N. Karavitaki, H.E. Turner, C.B.T. Adams et al., Surgical debulking of pituitary macroadenomas causing acromegaly improves control by lanreotide. Clin. Endocrinol. 68(6), 970\u2013975 (2008). https:\/\/doi.org\/10.1111\/j.1365-2265.2007.03139.x","journal-title":"Clin. Endocrinol."},{"issue":"1","key":"3877_CR59","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1530\/eje.1.01824","volume":"152","author":"P Petrossians","year":"2005","unstructured":"P. Petrossians, L. Borges-Martins, C. Espinoza et al., Gross total resection or debulking of pituitary adenomas improves hormonal control of acromegaly by somatostatin analogs. Eur. J. Endocrinol. 152(1), 61\u201366 (2005). https:\/\/doi.org\/10.1530\/eje.1.01824","journal-title":"Eur. J. Endocrinol."},{"issue":"1","key":"3877_CR60","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s11102-023-01360-1","volume":"27","author":"A Giustina","year":"2024","unstructured":"A. Giustina, N. Biermasz, F.F. Casanueva et al., Consensus on criteria for acromegaly diagnosis and remission. Pituitary 27(1), 7\u201322 (2024). https:\/\/doi.org\/10.1007\/s11102-023-01360-1","journal-title":"Pituitary"},{"issue":"12","key":"3877_CR61","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/S2213-8587(21)00235-7","volume":"9","author":"M Fleseriu","year":"2021","unstructured":"M. Fleseriu, R. Auchus, I. Bancos et al., Consensus on diagnosis and management of Cushing\u2019s disease: a guideline update. Lancet Diabetes Endocrinol. 9(12), 847\u2013875 (2021). https:\/\/doi.org\/10.1016\/S2213-8587(21)00235-7","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"6","key":"3877_CR62","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1046\/j.1365-2265.2003.01784.x","volume":"58","author":"Y Greenman","year":"2003","unstructured":"Y. Greenman, G. Ouaknine, I. Veshchev, I.I. Reider-Groswasser, Y. Segev, N. Stern, Postoperative surveillance of clinically nonfunctioning pituitary macroadenomas: markers of tumour quiescence and regrowth. Clin. Endocrinol. 58(6), 763\u2013769 (2003). https:\/\/doi.org\/10.1046\/j.1365-2265.2003.01784.x","journal-title":"Clin. Endocrinol."},{"issue":"5","key":"3877_CR63","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1111\/j.1365-2265.2009.03583.x","volume":"71","author":"EP O\u2019Sullivan","year":"2009","unstructured":"E.P. O\u2019Sullivan, C. Woods, N. Glynn et al., The natural history of surgically treated but radiotherapy-na\u00efve nonfunctioning pituitary adenomas. Clin. Endocrinol. 71(5), 709\u2013714 (2009). https:\/\/doi.org\/10.1111\/j.1365-2265.2009.03583.x","journal-title":"Clin. Endocrinol."},{"issue":"4","key":"3877_CR64","doi-asserted-by":"publisher","first-page":"E10","DOI":"10.3171\/2011.1.FOCUS10317","volume":"30","author":"CP Hofstetter","year":"2011","unstructured":"C.P. Hofstetter, B.J. Shin, L. Mubita et al., Endoscopic endonasal transsphenoidal surgery for functional pituitary adenomas. Neurosurg. Focus 30(4), E10 (2011). https:\/\/doi.org\/10.3171\/2011.1.FOCUS10317","journal-title":"Neurosurg. Focus"},{"issue":"3","key":"3877_CR65","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1055\/s-0036-1598022","volume":"78","author":"A Ajlan","year":"2017","unstructured":"A. Ajlan, A.S. Achrol, A. Albakr et al., Cavernous sinus involvement by pituitary adenomas: clinical implications and outcomes of endoscopic endonasal resection. J. Neurol. Surg. B Skull Base 78(3), 273\u2013282 (2017). https:\/\/doi.org\/10.1055\/s-0036-1598022","journal-title":"J. Neurol. Surg. B Skull Base"},{"key":"3877_CR66","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.wneu.2020.09.087","volume":"144","author":"H Borghei-Razavi","year":"2020","unstructured":"H. Borghei-Razavi, B.A. Muhsen, K. Joshi, T. Woodard, V.R. Kshettry, Endoscopic extracapsular resection of an adrenocorticotropic hormone\u2013secreting macroadenoma with selective resection of the medial cavernous sinus wall. World Neurosurg. 144, 199 (2020). https:\/\/doi.org\/10.1016\/j.wneu.2020.09.087","journal-title":"World Neurosurg."},{"issue":"10","key":"3877_CR67","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.3390\/brainsci12101354","volume":"12","author":"LJM de Mac\u00eado Filho","year":"2022","unstructured":"L.J.M. de Mac\u00eado Filho, A.V.G. Di\u00f3genes, E.G. Barreto et al., Endoscopic endonasal resection of the medial wall of the cavernous sinus and its impact on outcomes of pituitary surgery: a systematic review and meta-analysis. Brain Sci. 12(10), 1354 (2022). https:\/\/doi.org\/10.3390\/brainsci12101354","journal-title":"Brain Sci."},{"issue":"5","key":"3877_CR68","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1227\/neu.0000000000002109","volume":"91","author":"A Ishida","year":"2022","unstructured":"A. Ishida, H. Shiramizu, H. Yoshimoto et al., Resection of the cavernous sinus medial wall improves remission rate in functioning pituitary tumors: retrospective analysis of 248 consecutive cases. Neurosurgery 91(5), 775\u2013781 (2022). https:\/\/doi.org\/10.1227\/neu.0000000000002109","journal-title":"Neurosurgery"},{"key":"3877_CR69","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.wneu.2019.02.134","volume":"126","author":"Y Nagata","year":"2019","unstructured":"Y. Nagata, K. Takeuchi, T. Yamamoto et al., Removal of the medial wall of the cavernous sinus for functional pituitary adenomas: a technical report and pathologic significance. World Neurosurg. 126, 53\u201358 (2019). https:\/\/doi.org\/10.1016\/j.wneu.2019.02.134","journal-title":"World Neurosurg."},{"key":"3877_CR70","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/neuros\/nyx378","volume":"64","author":"EH Oldfield","year":"2017","unstructured":"E.H. Oldfield, Cushing\u2019s disease: lessons learned from 1500 cases. Neurosurgery 64, 27\u201336 (2017). https:\/\/doi.org\/10.1093\/neuros\/nyx378","journal-title":"Neurosurgery"},{"key":"3877_CR71","doi-asserted-by":"publisher","first-page":"106306","DOI":"10.1016\/j.clineuro.2020.106306","volume":"200","author":"AT Omar","year":"2021","unstructured":"A.T. Omar, D.G. Munoz, J. Goguen et al., Resection of the medial wall of the cavernous sinus in functioning pituitary adenomas: technical note and outcomes in a matched-cohort study. Clin. Neurol. Neurosurg. 200, 106306 (2021). https:\/\/doi.org\/10.1016\/j.clineuro.2020.106306","journal-title":"Clin. Neurol. Neurosurg."},{"key":"3877_CR72","doi-asserted-by":"publisher","first-page":"e280","DOI":"10.1016\/j.wneu.2018.06.012","volume":"117","author":"HH Park","year":"2018","unstructured":"H.H. Park, E.H. Kim, C.R. Ku, E.J. Lee, S.H. Kim, Outcomes of aggressive surgical resection in growth hormone\u2013secreting pituitary adenomas with cavernous sinus invasion. World Neurosurg. 117, e280\u2013e289 (2018). https:\/\/doi.org\/10.1016\/j.wneu.2018.06.012","journal-title":"World Neurosurg."},{"issue":"5","key":"3877_CR73","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.3171\/2014.6.JNS131994","volume":"121","author":"S Berkmann","year":"2014","unstructured":"S. Berkmann, S. Schlaffer, C. Nimsky, R. Fahlbusch, M. Buchfelder, Intraoperative high-field MRI for transsphenoidal reoperations of nonfunctioning pituitary adenoma. J. Neurosurg. 121(5), 1166\u20131175 (2014). https:\/\/doi.org\/10.3171\/2014.6.JNS131994","journal-title":"J. Neurosurg."},{"issue":"1","key":"3877_CR74","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s11102-014-0560-2","volume":"18","author":"PT Sylvester","year":"2015","unstructured":"P.T. Sylvester, J.A. Evans, G.J. Zipfel et al., Combined high-field intraoperative magnetic resonance imaging and endoscopy increase extent of resection and progression-free survival for pituitary adenomas. Pituitary 18(1), 72\u201385 (2015). https:\/\/doi.org\/10.1007\/s11102-014-0560-2","journal-title":"Pituitary"},{"issue":"2","key":"3877_CR75","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1530\/eje.1.01970","volume":"153","author":"R Fahlbusch","year":"2005","unstructured":"R. Fahlbusch, B.V. Keller, O. Ganslandt, J. Kreutzer, C. Nimsky, Transsphenoidal surgery in acromegaly investigated by intraoperative high-field magnetic resonance imaging. Eur. J. Endocrinol. 153(2), 239\u2013248 (2005). https:\/\/doi.org\/10.1530\/eje.1.01970","journal-title":"Eur. J. Endocrinol."},{"issue":"4","key":"3877_CR76","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.nec.2019.05.003","volume":"30","author":"PS Jones","year":"2019","unstructured":"P.S. Jones, B. Swearingen, Intraoperative MRI for pituitary adenomas. Neurosurg. Clin. N. Am. 30(4), 413\u2013420 (2019). https:\/\/doi.org\/10.1016\/j.nec.2019.05.003","journal-title":"Neurosurg. Clin. N. Am."},{"issue":"1","key":"3877_CR77","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/j.1365-2265.2005.02295.x","volume":"63","author":"Y Greenman","year":"2005","unstructured":"Y. Greenman, K. Tordjman, E. Osher et al., Postoperative treatment of clinically nonfunctioning pituitary adenomas with dopamine agonists decreases tumour remnant growth. Clin. Endocrinol. 63(1), 39\u201344 (2005). https:\/\/doi.org\/10.1111\/j.1365-2265.2005.02295.x","journal-title":"Clin. Endocrinol."},{"issue":"4","key":"3877_CR78","doi-asserted-by":"publisher","first-page":"D11","DOI":"10.1530\/EJE-21-0344","volume":"185","author":"Y Greenman","year":"2021","unstructured":"Y. Greenman, M.D. Bronstein, Cabergoline should be attempted in progressing non-functioning pituitary macroadenoma. Eur. J. Endocrinol. 185(4), D11\u2013D20 (2021). https:\/\/doi.org\/10.1530\/EJE-21-0344","journal-title":"Eur. J. Endocrinol."},{"issue":"2","key":"3877_CR79","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1097\/COC.0000000000000505","volume":"42","author":"RL Batista","year":"2019","unstructured":"R.L. Batista, N.R.C. Musolino, V.A.S. Cescato et al., Cabergoline in the management of residual nonfunctioning pituitary adenoma: a single-center, open-label, 2-year randomized clinical trial. Am. J. Clin. Oncol. 42(2), 221\u2013227 (2019). https:\/\/doi.org\/10.1097\/COC.0000000000000505","journal-title":"Am. J. Clin. Oncol."},{"issue":"4","key":"3877_CR80","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1677\/ERC-08-0181","volume":"15","author":"A Colao","year":"2008","unstructured":"A. Colao, C. Di Somma, R. Pivonello, A. Faggiano, G. Lombardi, S. Savastano, Medical therapy for clinically non-functioning pituitary adenomas. Endocr. Relat. Cancer 15(4), 905\u2013915 (2008). https:\/\/doi.org\/10.1677\/ERC-08-0181","journal-title":"Endocr. Relat. Cancer"},{"issue":"6","key":"3877_CR81","doi-asserted-by":"publisher","first-page":"933","DOI":"10.3171\/jns.1998.89.6.0933","volume":"89","author":"P Breen","year":"1998","unstructured":"P. Breen, J.C. Flickinger, D. Kondziolka, A.J. Martinez, Radiotherapy for nonfunctional pituitary adenoma: analysis of long-term tumor control. J. Neurosurg. 89(6), 933\u2013938 (1998). https:\/\/doi.org\/10.3171\/jns.1998.89.6.0933","journal-title":"J. Neurosurg."},{"issue":"5","key":"3877_CR82","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/0360-3016(93)90520-6","volume":"27","author":"MN Hughes","year":"1993","unstructured":"M.N. Hughes, K.J. Llamas, M.E. Yelland, L.B. Tripcony, Pituitary adenomas: long-term results for radiotherapy alone and post-operative radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 27(5), 1035\u20131043 (1993). https:\/\/doi.org\/10.1016\/0360-3016(93)90520-6","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"4","key":"3877_CR83","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/nrendo.2010.4","volume":"6","author":"F Castinetti","year":"2010","unstructured":"F. Castinetti, J. R\u00e9gis, H. Dufour, T. Brue, Role of stereotactic radiosurgery in the management of pituitary adenomas. Nat. Rev. Endocrinol. 6(4), 214\u2013223 (2010). https:\/\/doi.org\/10.1038\/nrendo.2010.4","journal-title":"Nat. Rev. Endocrinol."},{"issue":"2","key":"3877_CR84","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.ijrobp.2004.09.058","volume":"62","author":"P Colin","year":"2005","unstructured":"P. Colin, N. Jovenin, B. Delemer et al., Treatment of pituitary adenomas by fractionated stereotactic radiotherapy: a prospective study of 110 patients. Int. J. Radiat. Oncol. Biol. Phys. 62(2), 333\u2013341 (2005). https:\/\/doi.org\/10.1016\/j.ijrobp.2004.09.058","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"3","key":"3877_CR85","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1056\/NEJM199701163360303","volume":"336","author":"J Estrada","year":"1997","unstructured":"J. Estrada, M. Boronat, M. Mielgo et al., The long-term outcome of pituitary irradiation after unsuccessful transsphenoidal surgery in Cushing\u2019s disease. N. Engl. J. Med. 336(3), 172\u2013177 (1997). https:\/\/doi.org\/10.1056\/NEJM199701163360303","journal-title":"N. Engl. J. Med."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-024-03877-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-024-03877-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-024-03877-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,10]],"date-time":"2024-08-10T06:20:13Z","timestamp":1723270813000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-024-03877-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,18]]},"references-count":85,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,9]]}},"alternative-id":["3877"],"URL":"https:\/\/doi.org\/10.1007\/s12020-024-03877-2","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,18]]},"assertion":[{"value":"25 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}